Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
11.21
+0.77 (7.38%)
Jan 14, 2026, 12:28 PM EST - Market open
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $1.51 billion as of January 14, 2026. Its market cap has increased by 350.47% in one year.
Market Cap
1.51B
Enterprise Value
1.29B
1-Year Change
350.47%
Ranking
Category
Stock Price
$11.21
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $1.51B, an increase of 865.88%. That is a compound annual growth rate of 61.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 1.41B | 17.83% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | 156.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |